Get started
Author

Christel Herzog

Observed name: C Herzog
ORCID: 0009-0005-4119-8556
Observed ORCID: 0009-0005-4119-8556
OpenAlex ID: A5071920716
Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells.
1997 · B Barleon, G Siemeister, et al. · PubMed · 214
Mapping of the Sites for Ligand Binding and Receptor Dimerization at the Extracellular Domain of the Vascular Endothelial Growth Factor Receptor FLT-1
1997 · Bernhard Barleon, Frank Totzke, et al. · Journal of Biological Chemistry · 196
Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors
2001 · Bernhard Barleon, Petra Reusch, et al. · Angiogenesis · 111
Highly potent anti-SARS-CoV-2 multivalent DARPin therapeutic candidates
2020 · Marcel Walser, Sylvia Rothenberger, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 31
PDF
The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024 · Matteo Bianchi, Christian Reichen, et al. · Cancer Immunology Research · 17
PDF
Profound Functional Suppression of Tumor‐Infiltrating T‐Cells in Ovarian Cancer Patients Can Be Reversed Using PD‐1‐Blocking Antibodies or DARPin® Proteins
2020 · Emelie Foord, Charlotte Klynning, et al. · Journal of Immunology Research · 11
PDF
Oxygen‐derived radicals stimulate renin release of isolated juxtaglomerular cells
1994 · Jan Galle, Christel Herzog, et al. · FEBS Letters · 9
MP0533: A Multispecific Darpin CD3 Engager Targeting CD33, CD123, and CD70 for the Treatment of AML and MDS Designed to Selectively Target Leukemic Stem Cells
2022 · Matteo Bianchi, Christian Reichen, et al. · Blood · 5
Abstract 1890: A solution to T-cell engager toxicity: An anti-CD3 Prodrug DARPin (CD3-PDD) shows no toxicity, but potent anti-tumor activity in a humanized mouse model
2021 · Andreas Bosshart, Julia Katharina Ahlskog, et al. · Cancer Research · 3
Abstract 339: Development of 212Pb-based Radio-DARPin therapy (RDT) for the treatment of mesothelin (MSLN)-positive solid tumors
2025 · Stephan Wullschleger, Amal Saidi, et al. · Cancer Research · 1
842 Unlocking precision: a next-generation multi-specific CD3 Switch-DARPin with enhanced function to tackle the current limitations of T cell engagers in ovarian cancer
2024 · Joanna Robinson, Matteo Bianchi, et al. · Journal for ImmunoTherapy of Cancer · 1
Avidity-Engineered CD3 Engaging DARPin ® Targeting Three Tumor Associated Antigens Induce Strong and Specific T Cell Dependent Killing of AML Cells with Potential for Improved Safety
2021 · Matteo Bianchi, Nina Reschke, et al. · Blood · 1
Data from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024 · Matteo Bianchi, Christian Reichen, et al.
Supplementary Figure S12 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024 · Matteo Bianchi, Christian Reichen, et al.
PDF
Supplementary Figure S1 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024 · Matteo Bianchi, Christian Reichen, et al.
Supplementary Figure S16 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024 · Matteo Bianchi, Christian Reichen, et al.
Supplementary Figure S2 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024 · Matteo Bianchi, Christian Reichen, et al.
Supplementary Figure S15 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024 · Matteo Bianchi, Christian Reichen, et al.
Supplementary Figure S3 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024 · Matteo Bianchi, Christian Reichen, et al.
Supplementary Figure S5 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024 · Matteo Bianchi, Christian Reichen, et al.
Supplementary Figure S13 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024 · Matteo Bianchi, Christian Reichen, et al.
Supplementary Figure S17 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024 · Matteo Bianchi, Christian Reichen, et al.
PDF
Supplementary Figure S10 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024 · Matteo Bianchi, Christian Reichen, et al.
Supplementary Figure S14 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024 · Matteo Bianchi, Christian Reichen, et al.
PDF
Supplementary Figure S4 from The CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell–Mediated Killing of AML Leukemic Stem Cells
2024 · Matteo Bianchi, Christian Reichen, et al.
Works count: 44
Citation count: 600
H-index: 7
I10-index: 6
Year
Topic
Type